Literature DB >> 11554590

Gene therapy for hemophilia B: AAV-mediated transfer of the gene for coagulation factor IX to human muscle.

P J Larson1, K A High.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11554590     DOI: 10.1007/978-1-4615-1277-6_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

Review 1.  Adeno-associated virus vectors: potential applications for cancer gene therapy.

Authors:  Chengwen Li; Dawn E Bowles; Terry van Dyke; Richard Jude Samulski
Journal:  Cancer Gene Ther       Date:  2005-12       Impact factor: 5.987

2.  Advances in Overcoming Immune Responses following Hemophilia Gene Therapy.

Authors:  Carol H Miao
Journal:  J Genet Syndr Gene Ther       Date:  2011-12-23

3.  Safety of AAV factor IX peripheral transvenular gene delivery to muscle in hemophilia B dogs.

Authors:  Virginia Haurigot; Federico Mingozzi; George Buchlis; Daniel J Hui; Yifeng Chen; Etiena Basner-Tschakarjan; Valder R Arruda; Antoneta Radu; Helen G Franck; J Fraser Wright; Shangzhen Zhou; Hansell H Stedman; Dwight A Bellinger; Timothy C Nichols; Katherine A High
Journal:  Mol Ther       Date:  2010-04-27       Impact factor: 11.454

4.  Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.

Authors:  Alberto Auricchio; Erin O'Connor; Daniel Weiner; Guang-Ping Gao; Markus Hildinger; Lili Wang; Roberto Calcedo; James M Wilson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 5.  The role of the adeno-associated virus capsid in gene transfer.

Authors:  Kim M Van Vliet; Veronique Blouin; Nicole Brument; Mavis Agbandje-McKenna; Richard O Snyder
Journal:  Methods Mol Biol       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.